Form 4: Clene Inc. Director Receives Stock Option Grant

Director Jonathon Gay was granted stock options for 3,728 shares of Clene Inc. common stock on May 21, 2026.

Summary

• Director Jonathon Gay received two separate grants of stock options totaling 3,728 shares.
• The exercise price for all granted options is $6.81 per share.
• The options expire on May 20, 2036.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on the company's financial trajectory.

Positives

• Alignment of director interests with shareholders through equity-based compensation.

Negatives

• Issuance of stock options results in potential future dilution for existing shareholders.

Risks

• Market price volatility may impact the value of the options relative to the $6.81 exercise price.

Future Outlook

The options vest over time (for the 1,500 share portion) or immediately (for the 2,228 share portion), indicating a mix of immediate compensation and long-term retention.

Management Comments

• No specific management commentary provided in this regulatory filing.

Industry Context

StockSavvy.ai notes that equity grants to directors are standard corporate governance practices intended to incentivize long-term performance and align leadership with shareholder outcomes.

Comparison to Industry Standards

• The use of the 2020 Stock Plan for director compensation is consistent with standard practices for small-cap biotechnology and pharmaceutical companies.
• Vesting schedules are typical for board-level equity compensation.

Corporate Governance

Stakeholder Impact

• Minor dilution impact on existing shareholders due to the issuance of new options.

Next Steps

• Vesting of 1,500 options in 12 equal monthly installments starting June 21, 2026.

Key Dates

Keywords

Clene Inc, CLNN, Form 4, Insider Trading, Stock Options, Director Compensation